First Republic Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 18,542 shares of CABA stock, worth $109,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,542
Previous 23,455
20.95%
Holding current value
$109,397
Previous $302,000
6.62%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
146Shares Held
50.2MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$32.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$28.1 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$22.9 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$17.9 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$15.4 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $171M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...